Search Results 571-580 of 18383 for total bilirubin

1. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis - Mayo Clinic

   ... total bilirubin ≤1.5 x ULN * sodium \>135 mmol/L * potassium between 3.6 and 5.0 mmol/L 11. Have an estimated glomerular filtration rate (eGFR) ≥45 mL/min ...

2. Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

   Total bilirubin =< 1.5 x ULN (does not apply to patients with isolated ... bilirubin should be =< 2 x ULN); Alkaline phosphatase =< 3 x ULN; Serum ...

3. A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor - Mayo Clinic

   Serum creatinine must be <2.0mg/dl; Total bilirubin and AST <3x normal; Infectious disease marker (IDM) monitoring will be performed per institutional ...

4. Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome - Mayo Clinic

   * Total bilirubin ≤ institutional upper limit of normal Note: Higher bilirubin ... serum glutamate pyruvate transaminase \[SGPT\]) =\< 1.5 x institutional ...

5. Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma - Mayo Clinic

   Total bilirubin =< 1.5 x institutional upper limit of normal; Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine ...

6. Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE) - Mayo Clinic

   - total bilirubin ≥ 2.0 mg/dL (subjects with a documented history of Gilbert's syndrome can be enrolled if the direct bilirubin is within normal reference ...

7. Alisertib in Treating Young Patients with Recurrent or Refractory Solid Tumors or Leukemia - Mayo Clinic

   >= 16 years: 1.7 (male), 1.4 (female). Total bilirubin ≤ 1.5 x upper limit of normal (ULN) for age; Serum glutamic pyruvate transaminase (SGPT) (alanine ...

8. Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus - Mayo Clinic

   Total bilirubin level ≥ 1.3 mg/dL (22.2 µmol/L) (patients with a documented history of Gilbert's syndrome can be enrolled if direct bilirubin is within ...

9. Torsemide (oral route) - Side effects & dosage - Mayo Clinic

   Torsemide is used to help treat fluid retention (edema) and swelling that is caused by congestive heart failure, liver disease, kidney disease. It belongs to ...

10. Combining Immunotherapy And Radiation Therapy To Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial - Mayo Clinic

    Total bilirubin ≤ institutional upper limit of normal (ULN) unless history of Gilbert's disease (within 28 days prior to registration). Participants with ...